Member Info for Aldebaran

Seriously question guys. What news is due ??

Surely can't be a placing as they have raised recently but price behaving like there is one coming at a big discount but there can't be so what else is it??

What is next bit of news due here at AFC ?

You can be assured it is not what most here are wanting to hear? Are results due???

AFC failed to deliver any meaningful sales they are a cereal disappointer. The company was shrewd or lucky to get a raise away at 15p so that's one good thing but clearly now price relating back to where it belongs for a highly speculative high risk stock. 75m is to much guys. This should be valued around 2p per share until it proves itself. if it proves itself.

It's OK getting caught up in hope hipe potential until it's time to deliver. The future might be hydrogen but what is the right now? Not afc

AFC is all hope hipe potential there is so much future success already we'll baked into the market cap I hate to say it but I have repeatedly told folk this is headed to 2p which given the serial disappointments this company has delivered and the risk involved and the serious lack of revenues is about where this belongs.

It might come great in a few years it might not right now it's headed DOWN fast IMO. Few bounce trade opportunities on the way down is all.

See you at 2p

Avacta won't be able to raise anywhere near enough on AIM to fund the pipeline. The strategy is clear for me.

Release Pipeline to whet appetite of BP

Divest Dx to become a pure Tx play

Bring onboard specialist institutions in private placement

List on NASDAQ

Get taken out

Avacta cash position after paying Oct CLN in cash will be around 18m which will provide avacta with a 9m cash runway roughly. Throw in the sale of Dx for 15m conservatively and their is easy enough to see avacta through to end p1b, a LD, NASDAQ listing or a TO so I'm not concerned at all about cash.

Company are focusing more on next generation pipeline and I think that's because 1st gen is in the bag. POC/MOA proven and dox will be dox. Ava6k is coming to market and has the SAB managing it through to achieve fast track or accelerated approval from the FDA. For me, this is done hence why company aren't talking about it much now and there focus is elsewhere.

Pipeline reveal at end Oct and they should spell out the TAM plus show some of the pre clinical data which is something everyone will look forward to and rightly expect the SP to increase off the back of it.

Avacta have now moved onto phase 1b with our lead clinical asset, that in itself is a value inflecion point.

UK aim market still just Meh...

But avacta are doing and saying all the right things IMV and happy to add again today.

GSA still need to close. It's getting more precarious for them with each update from Avacta as sooner or later thus scientific progress will be recognised

Spreadbet firms still won't allow long positions

Touk we don't know when enrolling started (presume not today)

We don't know how long it will take. Given exceptional data I think it will be easier to recruit patients

Either way p1a is over and avacta have moved on. Without you seemingly.

Over 30m in cash in June, dx days numbered with indicative offers received and it has hit EBITDA profitability so plenty more cash coming on and hughly successful phase 1a trial over with p1b enrollment ongoing.

Investor meet later today. Bullish

New management team in place with drive and credibility saying P1b for H2 2024. That remains the target and remains 100% on track. That's a fact.

Financial losses are expected and won't surprise anyone

Mcsquares I find this share to be highly manipulated I.e. when share price is rallying strongly the spreadbet firms are open for longs.

Want to buy the pullback instead? Forget about it. Closed for business. You can't win at avacta unless you buy and hold at the moment due to heavi manipulation

I see sorry I only skim read most people's posts as they are a bit blah. I tend to read yours though. One of the decent posters here

Icecool you calling me windy or did you make a copy and paste mistake? I am not wyndrum.

Anyway I came here to post a remark about spreadbet firms being close only for long as I can remember... does anybody else see that as a bit weird? Not being able to open up leveraged positions on avacta on IG for months and spreadex for 4 weeks or more now

I remember at 40p people were thinking it will go down forever and rallied to 85p. Just think. Someone actually sold around 39p! Must have been gutted.

Again now, someone sold at 48p yesterday and yet huge buys flooding in now.

Mugged off again. Constantly. Pi's done have a chance when they are so quick to the sell button and are under researched.

Avacta have got a platform that works and a lead clinical asset odds on to replace doxorubicin as standard of care. Company valued at 200m is a mind blowing opportunity and yet because of manipulation and FUD and because others are selling... people sell. Unreal. You get what you deserve. Plenty news inbound and one day an offer will come in out the blue and you're either in and loaded or out and gutted. All for trying to be greedy and earn/save an extra 10% or something.

Avacta is a once in a lifetime opportunity and I suggest people invest with that in mind. I have stumbled on this by accident and now am almost entirely invested in it when I used to trade. No need going forward I'll be in the Maldives with my millions.

Worked buys doing through. GSA getting out with minimal damage. All thanks to frightened PI's selling out of shear panic.

People never learn

Christina must be scratching her head at this frankly bizzare share price action.

She's sat on one of the most if not the most exciting oncology platforms in the world. Precision works exactly as intended. It does what it says on the tin, it renders potent warheads inert until they reach the TME where they are activated by FAP .

CC has an entire pipeline of these FAP enabled drugs ready to release no doubt with some excellent pre clinical results supporting it.

The safety couldn't be any better. The initial efficacy looks encouraging. There's enough money in the bank for the foreseeable and high likelihood of more coming soon from dx sale. Avacta are sitting pretty and she's been really good at communicating with us all and yet the SP reaction has been dreadful. What more can she do? This market is pants. Aim is pants. Nefarious interests are manipulating. The science isn't the problem here.

All that said I think her reiterating that it works to people that already know it does is where avacta can improve. Hopefully in near future they get to give an oral presentation at one of these big oncology conferences and all the hard work with II's and BP in the background starts to pay off. A bit of MSM coverage would do wonders as well to really get the word out.

Spreadbet platforms STILL closed for new long positions lol

DB note released which is misleading at best but deliberate manipulation more likely.

GSA asked to be let out of there hole before avacta newsflow starts in earnest. I think so.

Whoever has or does sell below the last placing price of 50p is a absolute mug putting it mildy

As I've said before Thorn I don't for one minute believe in the efficient market hypothesis. The market misprices companies literally all the time. I think the market is made up of skittish aim investors and traders at the moment hence the volatility in the share price.

Need some II's on bored and looking like validation from a 3rd party then the trajectory will be much more clear and obvious but I and a few others see this already. Have added again today.

Avacta working wonders with Ribena.

They've really managed to fool everyone. Amazing!